Publications from our group concerning primary and secondary cancer of the liver

Bak-Fredslund KP, Keiding S, Villadsen GE, Kramer S, Schlander S, Sørensen M. [18F]-Fluoro-2-deoxy-D-galactose positron emission tomography/computed tomography as complementary imaging tool in patients with hepatocellular carcinoma. Liver Int 2020;40:447—455.

Rahmim A, Bak-Fredslund KP, Ashrafinia S, Lu L, Schmidtlein C R, Subramaniam RM, Morsing A, Keiding S, Horsager J, Munk OL. Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features. Euro J Radiol 2019;113:101—109.

Fode MM, Petersen JB, Sørensen M, Holt MI, Keiding S, Høyer M. 2-[18F]fluoro-2-deoxy-D-galactose positron emission tomography guided functional treatment planning of stereotactic body radiotherapy of liver tumours. Physics and Imaging in Radiation Oncology 2017;56:1614—1620.

Bak-Fredslund KP, Munk OL, Keiding S, Sørensen M. 2-[18F]fluoro-2-deoxy-D-galactose PET/CT of hepatocellular carcinoma is not improved by co-administration of galactose. J Nucl Med Biol 2016;43:577—580.

Fosby B, Melum E, Bjøro K, Bennet W, Rasmussen A, Andersen IM, Castedal M, Olausson M, Wibeck C, Gotlieb M, Gjertsen H, Toivonen L, Foss S, Makisalo H, Nordin A, Sanengen T, Bergquist A, Larsson ME, Boberg KM, Isoniemi H, Keiding S, Foss A, Line P-D, Frimann S, Schrumpf E, Ericzon B-J, H√∂ckerstedt K, Karlsen TH. The Nordic Liver Transplant Registry: Liver transplantation in the Nordic countries 1982-2013. Scand J Gastroent 2015;50:797—808.

Sørensen M. Hepatocellular carcinoma. In Functional Molecular Imaging in Hepatology (eds. Keiding S, Sørensen S), Bentham Science Publishers, 2012, pp. 87—94.

Sørensen M, Frisch M, Bender D, Keiding S. The potential use of 2-[18F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma. Eur J Nucl Med Molecular Imaging 2011; 38:1723—1731.

Weber B, Winterdahl M, Memon AA, Sorensen BS, Keiding S, Sorensen L, Nexo E, Meldgaard P. Erlotinib accumulation in brain metastases from non-small cell lung cancer. Visualisation by PET in a patient harbouring a mutation in the epidermal growth factor receptor. J Thoracic Oncol 2011; 6:1287—1289.

Mortensen LS, Buus S, Nordsmark M, Bentzen L , Munk OL, Keiding S, Overgaard J. Identifying hypoxia in human tumors: a correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode. Acta Oncol 2010; 49:934—940.

Fischer B, Lassen U, Mortensen J, Larsen S, Loft A, Bertelsen A, Ravn J, Clementsen P, Høgholm A, Larsen K, Rasmussen T, Keiding S, Gerke O, Skov B, Steffensen I, Hansen H, Vilmann P, Jacobsen G, Backer V, Maltbaek N, Pedersen J, Madsen H, Nielsen H, Højgaard L. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 2009; 361:32—39.

Memon AA, Jakobsen A, Dagnaes-Hansen F, Sørensen BS, Keiding S, Nexø E. Positron emission tomography (PET) imaging with [11C] labeled erlotinib. A micro-PET study on mice with lung tumor xenografts. Cancer Res 2009; 69:873—878.

Busk M, Jakobsen S, Keiding S, van der Kogel AJ, Bussink J, Overgaard J. Imaging hypoxia in xenografted and murine tumors with 18F-Fluoroazomycin arabinoside: A comparative study involving microPET, autoradiography, pO2-polarography, and fluorescence microscopy. Int J Radiat Oncol Biol Phys 2008; 70:1202—1212.

Johansen J, Buus S, Loft A, Keiding S, Overgaard M, Hansen HS, Grau C, Bundgaard T, Kirkegaard J, Overgaard J. Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study. Head Neck 2008; 30:471—478.

Sørensen M, Mortensen FV, Høyer M, Vilstrup H, Keiding S. Positronemissionstomografi har klinisk betydning ved planlægning af behandling af kolorektale levermetastaser - sekundærpublikation. Ugeskr Læger 2008; 170:1364—1366.

Sørensen M, Mortensen FV, Høyer M, Vilstrup H, Keiding S and The Liver Tumour Board at Aarhus University Hospital. FDG-PET improves management of patients with colorectal liver metastases allocated for local treatment: a consecutive prospective study. Scand J Surgery, 2007; 96:209—213.

Hutchings M, Loft A, Hansen M, Pedersen LM, Berthelsen AK, Keiding S, D'Amore F, Boesen AM, Roemer L, Specht L. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Haematologica 2006; 9:482—489.

Hutchings M, Loft A, Hansen M, Pedersen LM, Buhl T, Jurlander J, Buus S, Keiding S, D'Amore F, Boesen AM, Berthelsen AK, Specht L. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 2006; 107:52—59.

Buus S, Grau C, Munk OL, Rodell A, Jensen K, Mouridsen K, Keiding S. Individual radiation response of parotid glands investigated by dynamic 11C-methionine PET. Radiother Oncl 2006; 78:262—269.

Prytz H, Keiding S, Björnsson E, Broomé U, Almer S, Castedal M, Munk OL and The Swedish Internal Medicine Liver Club (SILK). Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation. Hepatology 2006; 44:1572—1580.

Sørensen M, Horsman MR, Cumming P, Munk OL, Keiding S. Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode pO2 measurements in murine tumors. Int J Radiat Oncol Biol Phys 2005; 62:854—861.

Buus S, Grau C, Munk OL, Bender D, Jensen K, Keiding S. 11C-methionine PET, a novel method for measuring regional salivary gland function after radiotheraphy of head and neck cancer. Radiother Oncol 2004; 73:289—296.

Grönroos T, Bentzen L, Marjamäki P, Murata R, Horsman MR, Keiding S, Eskola O, Haaparanta M, Minn H, Solin O. Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma. Eur J Nucl Med Mol Imaging 2004; 31:513—520.

Bentzen L, Keiding S, Nordsmark M, Falborg L, Hansen SB, Keller J, Nielsen OS, Overgaard J. Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours. Radiother Oncol 2003; 67:339—344.

Bentzen L, Keiding S, Horsman M, Falborg L, Hansen SB, Overgaard J. Assessment of hypoxia in experimental tumors by [18F]Fluoromisonidazole PET examination and pO2 electrode measurements. Influence of tumour volume and carbogen breathing. Acta Oncol 2002; 41:304—312.

Kaarstad K, Bender D, Bentzen L, Munk OL, Keiding S. Metabolic fate of 18F-FDG in mice bearing either SCCVII squamous cell carcinoma or C3H mammary carcinoma. J Nucl Med 2002; 43:940—947.

Bentzen L, Keiding S, Horsman MR, Falborg L, Hansen SB, Overgaard J. Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography. A study evaluating [18F]Fluoromisonidazole and [18F]Fluoro-2-deoxy-D-glucose. Acta Oncol 2000; 39:629—637.

Keiding S, Schiøtt KM, Vilstrup H, Gjedde A. Positron-emissionstomografi af levertumorer. Ugeskr Læger 1999; 161:6163—6165.

Keiding S, Hansen SB, Rasmussen HH, Gee A, Kruse A, Roelsgaard K, Tage-Jensen U, Dahlerup JF. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 1998; 28:700—706.